Atsushi Musha
Overview
Explore the profile of Atsushi Musha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Musha A, Kubo N, Kawamura H, Okano N, Onishi M, Ohtaka T, et al.
Clin Transl Radiat Oncol
. 2025 Feb;
52:100928.
PMID: 39995853
Background And Purpose: Despite recognizing the effectiveness of carbon-ion radiotherapy (C-ion RT) in treating head and neck adenoid cystic carcinoma (HN-ACC), the impact of perineural tumor spread (PNTS) on treatment...
2.
Meng X, Meng X, Ju Z, Sakai M, Li Y, Musha A, et al.
Radiother Oncol
. 2025 Jan;
204:110709.
PMID: 39798699
Background And Purpose: To develop a normal tissue complication probability (NTCP) model for predicting grade ≥ 2 acute oral mucositis (AOM) in head and neck cancer patients undergoing carbon-ion radiation...
3.
Shirai K, Aoki S, Endo M, Takahashi Y, Fukuda Y, Akahane K, et al.
Jpn J Radiol
. 2024 Sep;
43(2):186-199.
PMID: 39316285
Lung cancer has a poor prognosis, and further improvements in outcomes are needed. Radiotherapy plays an important role in the treatment of unresectable lung cancer, and there have been recent...
4.
Kanbe T, Musha A, Ogawa M, Yokoo S
Ear Nose Throat J
. 2023 Aug;
:1455613231186953.
PMID: 37551771
Among oral surgical conditions, supernumerary teeth of the dental arch is quite common. However, supernumerary teeth in the nasal cavity is a rarity and their diagnosis and treatment have not...
5.
Musha A, Ohno T
Pract Radiat Oncol
. 2023 Jun;
13(4):265-266.
PMID: 37391232
A 60-year-old woman received carbon ion radiotherapy (C-ion RT) (70.4 Gy [relative biological effectiveness]/16 fr) for undifferentiated pleomorphic sarcoma (UPS) (T4bN0M0) in the left pterygopalatine fossa. After 26 months, left...
6.
Musha A, Kubo N, Kawamura H, Okano N, Sato H, Okada K, et al.
Cancer Rep (Hoboken)
. 2023 Apr;
6(7):e1825.
PMID: 37115713
Background: Carbon-ion radiotherapy (C-ion RT) is effective for head and neck mucosal melanoma (HN-MM), including radioresistant mucosal melanoma. Melanoma also responds effectively to immune checkpoint inhibitors (ICIs). Data on the...
7.
Varnava M, Musha A, Tashiro M, Kubo N, Okano N, Kawamura H, et al.
Cancer Med
. 2023 Feb;
12(7):8267-8277.
PMID: 36799088
Background: Carbon ion radiotherapy (CIRT) has been applied in cancer treatment for over 25 years. However, guidelines for dose-volume constraints have not been established yet. The aim of this review...
8.
Musha A, Kubo N, Kawamura H, Okano N, Yanagisawa K, Sugawara K, et al.
J Radiat Res
. 2023 Jan;
64(2):420-427.
PMID: 36715177
Health care institutions provide prevention strategies for coronavirus disease 2019 and non-infectious disease care. We investigated the characteristics of patient contamination in a radiotherapy room by examining the trajectory and...
9.
Osu N, Musha A, Yumisaki H, Okada K, Kubo N, Okano N, et al.
J Clin Med
. 2022 Oct;
11(19).
PMID: 36233771
External auditory canal (EAC) cancer is a rare disease for which there are no adequate evidence-based treatment strategies. Radiotherapy is often used as the initial treatment to preserve the organ....
10.
Nachankar A, Musha A, Kubo N, Kawamura H, Okano N, Sato H, et al.
Radiother Oncol
. 2022 Mar;
170:143-150.
PMID: 35257851
Background And Purpose: Carbon-ion radiotherapy is an attractive treatment option for unresectable/inoperable, nonsquamous cancers of the head and neck. Intraocular hemorrhage associated with carbon-ion radiotherapy for head and neck cancer...